Applied Aerospace & Defense: A Much Healthier Proposition
Applied Aerospace & Defense shares have fallen 35% since their IPO, bringing its valuation to below 3x sales and roughly 14–15x EBITDA. The company reports improving earnings visibility, a growing $1.13 billion backlog, and second-half guidance implying strong sequential revenue growth and potential upside in adjusted EBITDA versus consensus.
Why it matters — AADX watchers would care because the article points to improving earnings visibility and a growing backlog at lower post-IPO valuations, which could reassess the company's financial health.